Julie Waras Brogren

Director of Finance/CFO chez ASCELIA PHARMA AB Fortune : 50 819 $ au 31/03/2024

Profil

Ms. Julie Waras Brogren is a Deputy CEO-Finance & Investor Relations at Ascelia Pharma AB.
She is on the Board of Directors at Ossiform ApS.
Ms. Brogren was previously employed as a President by Bresotec, Inc. and a Senior Director-Launch Office by Novo Nordisk A/S.
She received her graduate degree from Copenhagen Business School.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ASCELIA PHARMA AB 0,17%	13/07/2023	59 000 ( 0,17% )	50 819 $	31/03/2024

Postes actifs de Julie Waras Brogren

Sociétés	Poste	Début
ASCELIA PHARMA AB	Director of Finance/CFO	01/01/2023
Ossiform ApS	Director/Board Member	-

Anciens postes connus de Julie Waras Brogren

Sociétés	Poste	Fin
Bresotec, Inc.	President	01/06/2019
NOVO NORDISK A/S	Corporate Officer/Principal	-

Formation de Julie Waras Brogren

Copenhagen Business School

Graduate Degree